The industry has, for the last two decades, systematically rewarded activity. Flows follow managers who trade, who hedge, who talk, who post. The feedback loop is legible, and so is the selection pressure: a manager who says nothing for a quarter is presumed inactive, and inactivity is presumed to be negligence.
It is not negligence. It is work.
The architecture of patience
Patience is not the absence of action; it is the compounding of a prior decision not to act. Every position we hold represents dozens we declined. Every thesis we are still holding is one we have, repeatedly, re-underwritten. The calm surface of a concentrated book conceals a great deal of analytical labour.
What we are paid for is not the labour itself, but the sustained conviction that emerges from it. Markets will offer any number of reasons to sell; very few of them are changes to the underlying thesis. The discipline is to distinguish one from the other, in public, over and over, without falling into the comfort of either the bull or the bear narrative.
What has changed
Two things have changed the competitive landscape for patient capital, and they cut in opposite directions.
The first is the proliferation of short-horizon capital. Systematic strategies, factor tilts, and options overlays now absorb a large share of the price formation mechanism, particularly at the weekly and monthly frequencies. This makes short-term moves less interpretable as signal about underlying fundamentals, which is exactly the condition under which patient capital is paid best. When the marginal participant is indifferent to five-year outcomes, five-year outcomes become the residual free lunch.
The second is the narrowing of index returns. A handful of very large, very crowded positions now account for a disproportionate share of broad index performance. The cost of being different from the benchmark has become, in many windows, the cost of being different from a single sector. This is uncomfortable. It is also, historically, the condition under which the premium to independent underwriting has been highest.
The posture we recommend
We hold a simple view: the time to own concentrated, well-underwritten, differentiated positions is not when the benchmark is trailing them; it is when the benchmark is dominating them. That requires the willingness to underperform the crowd for long enough that the crowd stops crowding. In our experience, the crowd does eventually stop.
Patience is not a strategy. It is a precondition for any strategy that relies on price eventually returning to value. We have no view on when; we have a view on whether, and we are prepared to hold accordingly.